期刊文献+

三种自身触发的脉冲给药系统 被引量:3

Three programmed systems for pulsed drug delivery
下载PDF
导出
摘要 脉冲制剂致力于在疾病治疗需要的给药点定时定量的释放药物,而且可以避免患者在夜间服药或频繁服药,增加了患者的用药顺应性。本文主要介绍了3种可以自身触发的脉冲给药系统,它们不依赖外界化学触发因素,按照其触发机制分类,可分为以下几种,体系降解形成的脉冲释药,膨胀压形成的脉冲释药,体系降解和膨胀压共同形成的脉冲释药系统。本文就该种脉冲制剂的制备工艺、释放机制及影响因素做了分析和总结。自身触发的脉冲给药系统,其定时效果可以根据治疗目的进行调整,尤其是体系降解和膨胀压双重作用的脉冲制剂,有着广阔的发展前景。 Pulsed drug delivery(PDD),which can be released at well-defined time points as the therapy needs,can decrease the frequency and avoid taking drug at night,thus improving patient compliance.Here we introduce three kinds of programmed PDD systems independent of external chemical triggering;they are divided according to the triggering mechanisms:degradation-triggered PDD,osmotic pressure-triggered PDD,and both degradationi and osmotic pressure-triggered PDD.This paper reviews preparing technique,release mechanisms and influencing factors of the three PDD systems.The release profiles of pulsatile PDD can be regulated for different therapeutic needs,requiring no external triggers;especially that the PDD system triggered by both degradation and osmotic pressure has a bright future.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2010年第7期782-786,共5页 Academic Journal of Second Military Medical University
关键词 药物脉冲疗法 脉冲释放 体系降解 膨胀压 drug pulse therapy pulsed drug release degradation osmotic pressure
  • 相关文献

参考文献24

  • 1Stubbe B G, De Smedt S C, Demeester J. "Programmed polymerie devices" for pulsed drug delivery[J]. Pharm Res, 2004, 21 : 1732-1740.
  • 2Rothstein S N, Federspiel W J, Little S R. A unified mathematical model for the prediction of controlled release from surface and bulk eroding polymer matrices[J]. Biomaterials, 2009,30 : 1657-1664.
  • 3晏四平,全东琴.疫苗输送系统的研究进展[J].国外医学(药学分册),2001,28(3):174-178. 被引量:3
  • 4Cleland J L, Lim A, Barron L, Duenas E T, Powell M F. Development of a single-shot subunit vaccine for HIV-1 :Part 4. Optimizing microencapsulation and pulsatile release of MN rgp120 from biode gradable microspheres[J].J Contr Rel, 1997,47:135-150.
  • 5Sanchez A,Gupta R K, Alonso M J, Siber G R, Langer R. Pulsed controlled-release system for potential use in vaccine delivery[J].J Pharm Res,1996,85:547-552.
  • 6Jiang H L, Zhu K J. Pulsatile protein release from a laminated device comprising of polyanhydrides and pH-sensitive complexes[J].Int J Pharm, 2000,194 : 51-60.
  • 7Makino K, Idenuma R, Murakami T, Ohshima H. Design of a rate and time-programming drug release device using a hydrogel: pulsatile drug release from κ-carrageenan hydrogel device by surface erosion of the hydrogel[J]. Colloids Surf B Biointerfaces,2001,20:355- 359.
  • 8Wheatley M A, Langer R S, Eisen H N. System for controlled release of biologically active compounds: US Patent, 4933185 [P]. 1990-06-12.
  • 9Kibat P G,Igari Y,Wheatley M A,Eisen H N,Langer R. Enzymatically activated microeneapulated liposomes can provide pulsatile drug release[J]. FASEB J,1990,4:2533-2539.
  • 10潘卫三,甘勇.双室型渗透泵控释制剂的研究进展[J].沈阳药科大学学报,2000,17(2):146-151. 被引量:6

二级参考文献34

  • 1刘青弋.关于中国古典舞的基本范畴与概念丛[J].北京舞蹈学院学报,2006(2):18-28. 被引量:46
  • 2.中国药典1995年版二部[S].,1995.附录XC 66-67.
  • 3何绍雄.时间药理学[M].天津:天津科学技术出版社,1994.237.
  • 4[1]Langer R. New methods of drug delivery[J]. Science,1990, 249(4976): 1527 - 1533.
  • 5[2]Singh M, McGee JP, Li XM, et al. Biodegradable microparticles with an entrapped branched octameric peptide as a controlled-release HIV-1 vaccine [J]. J Pharm Sci,1997, 86(11):1229- 1233.
  • 6[3]Kawashima Y, Yamamoto H, Takeuchi H, et al. Properties of a peptide containing DL-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods[J]. Eur J Pharm Biopharm, 1998, 45(1):41-48.
  • 7[4]Lee HK, Park JH, Kwon KC. Double-walled microparticles for single shot vaccine[J]. J Controlled Release, 1997, 44(2,3) :283 - 293.
  • 8[5]Uchida T, Shiosaki K, Nakada Y, et al. Microencapsulation of hepatitis B core antigen for vaccine preparation [J].PharmRes, 1998, 15(11):1708- 1713.
  • 9[6]Uchida T, GotoS, FosterTP. Particle size studies for subcutaneous delivery of poly (lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation[J]. J Pharm Pharmacol, 1995, 47(7) :556 - 560.
  • 10[7]Chang A, Gupta RK. Stabilization of tetanus toxoid in poly (DL-lactic-co-glycolic acid) microspheres for the controlled release of antigen[J]. JPharm Sci, 1996, 85(2):129-132.

共引文献31

同被引文献30

  • 1张彦,张志荣.硫酸特布他林脉冲控释片的制备与释放机理研究[J].药学学报,2003,38(11):854-858. 被引量:8
  • 2张莉,陈大为,高子彬.法莫替丁定时释放小丸的释药机制[J].药学学报,2006,41(9):873-877. 被引量:3
  • 3Stubbe BG, De Smedt SC, Demeester J. "Programmed polymeric devices" for pulsed drug delivery[J]. Pharm Res, 2004,21(10) : 1 732.
  • 4Wheatly MA, Langer RS, Eisen HN. System for controll- ed release of biologically active compounds[P]. US Pat- ent: 4933185, 1990-06-12.
  • 5Satarkar NS, Hilt JZ. Magnetic hydrogel nanocomposites for remote controlled pulsatile drug release[J]. J Control Release, 2008,130 (3) : 246.
  • 6Philip AK, Pathak K, Shakya R Asymmetric membrance in menbrance capsules: a means for achieving delayed and osmotic flow of cefadroxil[J]. Eur J Pharm Bio- pharm, 2008,69(2):658.
  • 7Li B, Zhu JB, Zheng CL, et al. A novel system for threepulse drug release based on "'tablets in capsule devise[J]. Int JPharm, 2008,352(1-2) : 159.
  • 8崔德福.药剂学[M].第6版.北京:人民卫生出版社,2008:557.
  • 9Groning R, kuhland U. Use of a tube reserroir system for the pulsed release of nitroglycerin from transdermal plas- ters [J]. Pharmmazie, 1996,51 ( 5 ) : 345.
  • 10刘艳杰,项荣武.星点设计效应面法在药学试验设计中的应用[J].中国现代应用药学,2007,24(6):455-457. 被引量:238

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部